Is it safe to administer prucalopride to a patient with acute abdomen and clinical or radiologic features of intestinal obstruction?

No, prucalopride is absolutely contraindicated in acute abdomen with features of obstruction

Prucalopride must never be administered to patients with intestinal obstruction, as this represents an absolute contraindication according to FDA labeling and clinical guidelines. 1

Why This Is Dangerous

Prucalopride is a selective 5-HT4 receptor agonist that increases the amplitude of colonic high-amplitude propagated contractions and stimulates peristalsis 2. In the setting of mechanical obstruction, enhancing motility against a fixed obstruction can lead to:

• Bowel perforation - forcing contents against an obstructed segment
• Ischemic injury - increased intraluminal pressure compromising blood flow
• Clinical deterioration - worsening of an already critical situation

FDA Contraindications Are Explicit

The FDA label specifically lists as contraindications 1:

• Intestinal perforation or obstruction due to structural or functional disorder of the gut wall
• Obstructive ileus
• Severe inflammatory conditions (Crohn's disease, ulcerative colitis, toxic megacolon/megarectum)

Clinical Guidelines Confirm This

The 2023 AGA-ACG guidelines clearly state that prucalopride is contraindicated in patients with intestinal perforation or obstruction 2. This medication is indicated exclusively for chronic idiopathic constipation in otherwise stable patients, not acute surgical or obstructive conditions.

Critical Distinction: Ileus vs. Obstruction

While some research suggests prucalopride may help in non-obstructive paralytic ileus in critically ill patients 3, 4, this is fundamentally different from mechanical obstruction:

• Paralytic ileus = functional problem with no mechanical blockage - prucalopride may be considered in select cases
• Mechanical obstruction = physical blockage requiring surgical evaluation - prucalopride is absolutely contraindicated

What To Do Instead

In acute abdomen with obstructive features:

1. NPO (nothing by mouth) and nasogastric decompression
2. IV fluid resuscitation
3. Urgent surgical consultation
4. CT imaging to define anatomy and identify transition point
5. Serial abdominal exams to monitor for peritonitis

Never attempt pharmacologic stimulation of an obstructed bowel - this prioritizes patient safety and prevents catastrophic complications including perforation and death.